Quantification of the cell frequencies indicated that total (CD56+) NK cells were significantly reduced in NAFLD patients compared with HVs, but there was no difference in total NK cell frequency between patients with early fibrosis (F0–2) and advanced fibrosis (F3–4) (Figure 1B). The gene discussed is NCAM1; the disease is metabolic dysfunction-associated steatotic liver disease.